ClinicalTrials.gg
CompletedNCT03343080Updated Sep 27, 2019Results posted

Lidocaine as an Endotracheal Tube (ETT) Cuff Media

A Phase 2 interventional study of 1.8% lidocaine plus 0.76% sodium bicarbonate and Air in Cardiac Disease, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-09-27.

Sponsored by Mayo Clinic · Phase 2, Interventional, and Supportive care

Phase
Phase 2
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 22 studies in Heart Diseases by Mayo Clinic — 3 open to participants now, 4 under way, none of them phase 3. Heart Diseases · Mayo Clinic.

Started
2018
with 1 other
Phase 2
2 of 22
none open now
Registered
12th of 22
by date

Among the 22 studies in Heart Diseases by Mayo Clinic, this one is one of 2 that started in 2018, is one of 2 in phase 2, and was the 12th registered.

By phase

22 studies; the count open now beside each. This study's row is marked.

Observational12 · 1 open
No phase5 · 2 open
Other kind2 · 0 open
Phase 2this study2 · 0 open
Phase 2/31 · 0 open

By the year they started

First in 1997; this study’s year is marked. 2 started in 2018.

Size and results

Median enrollment 42 across the 8 interventional studies, 1,200 across the 9 observational. Of the 16 that completed or were terminated, 2 (13%) have results posted.

Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 22 studies in Heart Diseases by Mayo Clinic, or all of them as a file.
02

Study summary

Researchers will compare the effects of lidocaine versus air, as a way to fill the breathing tube cuff which is gently inflated to hold in place the trachea (airway) during surgery. Air is the traditional method used to inflate the breathing tube cuff. Researchers wish to find if lidocaine works better than air to facilitate tolerance to the breathing tube (decreased coughing, sore throat, hoarseness). They also want to learn more about its effectiveness for this particular surgical intervention.

Read the detailed description

At the induction of anesthesia, Participants will be breathing 100% oxygen via a face mask and then, become anesthetized according to a standard protocol and at the discretion of the attending anesthesiologist. Participants will be receive fentanyl, lidocaine and either succinylcholine or vecuronium to facilitate tracheal intubation. Laryngoscopy will then be performed and the trachea intubated with a standard cuffed ETT. Inflation of the ETT cuff will be performed in accordance with the randomization of either air or 1.8% lidocaine/0.76% solution until such time as there is no air leak around the tube when administering positive pressure to 20 cm H2O. Anesthesia will be maintained with volatile anesthetic with or without a Propofol infusion. Vecuronium will be used to maintain the ulnar nerve train-of-four at 0-3 of four twitches. Lungs will be mechanically ventilated with tidal volumes of 6-8 mL/kg to maintain end-tidalCO2 concentration at 30-35 mm Hg. Anesthesia maintenance will occur until the near end of the surgical procedure. The volatile anesthetic will be discontinued and Propofol will be initiated via a continuous infusion to facilitate transportation to the intensive care unit (ICU). After arrival to the ICU, Neuromuscular blockade will then be antagonized with neostigmine and glycopyrrolate, and the pharynx being gently suctioned under direct vision. Mechanical ventilation to be maintained until swallowing or spontaneous respiration begins, and then, converted to assisted manual ventilation. Extubation will be performed when all of the following criteria are met: 1) full reversal of neuromuscular block (ulnar nerve T4/T1 ratio 1:1, with sustained tetanus at 50 Hz for 5 s and no fade); 2) spontaneous ventilation; and 3) the ability to follow verbal commands (eye opening or hand grip) or demonstrate purposeful unilateral movement (attempting self-extubation); 4) demonstration of hemodynamic stability; 5) adequate hemostasis with combined chest tube output \< 100 ml/hour.

The Participant then will be closely monitored as a 1:1 by the room nurse, and by other staff (respiratory therapist, and ICU fellows and consultants) for toleration of the ventilator (coughing, double triggering, "bucking," etc.). on the cardiac surgical intensive care unit. Sedation amount will be recorded electronically once the patient lands in the ICU, until the time of extubation. A member from the study team will physically record "yes," or "no," on the form provided regarding the patient coughing, complaining of a sore throat or difficulty swallowing, having hoarseness or difficulty speaking.

03

Conditions studied

  • Cardiac Disease

Browse trials for

Keywords

  • Cardiac Surgery
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Patients who meet the inclusion criteria below and are expected to require ventilatory support for a period of less than 5 hours post-operatively in the cardiac ICU will be enrolled.

Inclusion criteria

Inclusion Criteria:

  • All patients > 18 years of age (male and female) who will receive general anesthesia for cardiac surgery at St. Mary's Hospital (SMH) in Rochester, Minnesota
  • Cardiac surgery includes: single valve repair, myectomy, cabbage, pericardectomy.
  • (ASA) physical status I-III

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years old at time of surgery
  • Patients who are not sent to the cardiac ICU post-operatively
  • Patients who are anticipated to have a difficult tracheal intubation
  • Patients having risk factors of postoperative aspiration of gastric contents
  • Patients who have respiratory disease or recent respiratory tract infection
  • > 1 attempt to secure an airway
  • Patients undergoing transcatheter aortic valve replacement (TAVR) procedures or any form of "robotic" procedures
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Phase 2
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    Buffered Lidocaine

    At the induction of anesthesia, patients will be breathing 100% oxygen via a face mask and then, become anesthetized according to a standard protocol and at the discretion of the attending anesthesiologist. For cardiac surgery patients randomized to the buffered lidocaine arm, the operating room registered respiratory therapist (OR RRT) will inflate the endotracheal tube cuffs with the study drug containing 1.8% lidocaine plus 0.76% sodium bicarbonate until abatement of the air leak at 20 cm of water. The intervention will take place while in the operating room. The room nurse anesthetist (CRNA) or anesthesiologist will be aware of the amount of solution instilled in the ETT cuff. The patient will remain intubated after the surgery is complete and will be taken to the cardiac surgical ICU.

    Drug: 1.8% lidocaine plus 0.76% sodium bicarbonate

  • Placebo comparator
    Air

    At the induction of anesthesia, patients will be breathing 100% oxygen via a face mask and then, become anesthetized according to a standard protocol and at the discretion of the attending anesthesiologist. For cardiac surgery patients randomized to the air arm, the operating room registered respiratory therapist (OR RRT) will inflate the endotracheal tube cuffs with air until abatement of the air leak at 20 cm of water. The intervention will take place while in the operating room. The room nurse anesthetist (CRNA) or anesthesiologist will be aware of the amount of air in the ETT cuff. The patient will remain intubated after the surgery is complete and will be taken to the cardiac surgical ICU.

    Other: Air

Interventions

  • Drug1.8% lidocaine plus 0.76% sodium bicarbonate

    Drug pages: Lidocaine · Sodium Bicarbonate

    At the time of intubation, the endotracheal tube cuff will be inflated with a solution containing 1.8% lidocaine plus 0.76% sodium bicarbonate until loss of air leak at a positive pressure of 20 cm of water. This solution will remain in situ through the duration of cardiac surgery, transportation to the intensive care unit, and continued to the time of extubation.

  • OtherAir

    At the time of intubation, the endotracheal tube cuff will be inflated with air until loss of air leak at a positive pressure of 20 cm of water. The air will remain in situ through the duration of cardiac surgery, transportation to the intensive care unit, and continued to the time of extubation.

06

What researchers measure

Primary outcomes

  1. Total Sedation Requirements

    Total amount of Propofol dose used as measured in total milligrams.

    Time frame: baseline through extubation

Secondary outcomes

  1. Total Duration of Mechanical Ventilation

    Total amount of time that the participant is intubated as measured in minutes.

    Time frame: baseline through extubation

  2. Richmond Agitation-Sedation Score (RASS)

    The Richmond Agitation-Sedation Scale (RASS) is a medical scale used to measure the agitation or sedation level of a patient.. It is a 10-point scale comprised of four levels of agitation (+1 to +4), one level defining a calm and alert state (0) and five levels of sedation (-1 to -5). The higher the positive number (+) the more agitated or combative a patient is and the higher the negative number (-) the deeper the sedation of the patient.

    Time frame: 4 hours post-extubation

07

Results

Posted Sep 27, 2019

Participant flow

Participant flow — Overall Study
MilestoneBuffered LidocaineAir Only
Started1418
Completed1418
Not completed00

Outcome measures

PrimaryTotal Sedation Requirements

Total amount of Propofol dose used as measured in total milligrams.

Time frame:
baseline through extubation
Reported as:
Mean · milligrams
Total Sedation Requirements
milligramsBuffered LidocaineAir Only
Total Sedation Requirements325 ± 2481158 ± 1426
SecondaryTotal Duration of Mechanical Ventilation

Total amount of time that the participant is intubated as measured in minutes.

Time frame:
baseline through extubation
Reported as:
Median · minutes
Total Duration of Mechanical Ventilation
minutesBuffered LidocaineAir Only
Total Duration of Mechanical Ventilation499 (440 to 613)529 (380 to 700)
Statistical analysis
  • Buffered Lidocaine vs Air Only · Wilcoxon (Mann-Whitney) · p = 0.776
SecondaryRichmond Agitation-Sedation Score (RASS)

The Richmond Agitation-Sedation Scale (RASS) is a medical scale used to measure the agitation or sedation level of a patient.. It is a 10-point scale comprised of four levels of agitation (+1 to +4), one level defining a calm and alert state (0) and five levels of sedation (-1 to -5). The higher the positive number (+) the more agitated or combative a patient is and the higher the negative number (-) the deeper the sedation of the patient.

Time frame:
4 hours post-extubation
Reported as:
Mean · score on a scale
Richmond Agitation-Sedation Score (RASS)
score on a scaleBuffered LidocaineAir Only
Richmond Agitation-Sedation Score (RASS)-0.2 ± 0.4-0.4 ± 0.5
Statistical analysis
  • Buffered Lidocaine vs Air Only · t-test, 2 sided · p = 0.296

Adverse events

Collected over Adverse events were recorded from baseline to 4 hours post extubation for each subject.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Buffered Lidocaine0/14 (0%)0/14 (0%)14/14 (100%)
Air Only0/18 (0%)0/18 (0%)18/18 (100%)
Most frequent other events
Most frequent other events
EventBuffered LidocaineAir Only
Hoarseness presentGeneral disorders10/1415/18
CoughGeneral disorders4/147/18
Difficulty swallowingGeneral disorders1/142/18
Agitation or restlessnessGeneral disorders0/141/18

Baseline characteristics

Age, Continuous
Age, Continuous(years)Buffered LidocaineAir OnlyTotal
Mean62.1 ± 14.959.4 ± 16.660.7 ± 15.8
Sex: Female, Male
Sex: Female, Male(Participants)Buffered LidocaineAir OnlyTotal
Female3710
Male111122
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Buffered LidocaineAir OnlyTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)Buffered LidocaineAir OnlyTotal
United States141832
08

Study locations

1 site
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 27, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03343080
Lead sponsor
Mayo Clinic
Responsible party
Troy G. Seelhammer (Assistant Professor of Anesthesiology, Mayo Clinic) — Principal investigator
First posted
Nov 17, 2017
Start date
Jul 27, 2018
Primary completion
Oct 1, 2018
Completion
Aug 1, 2019
Results posted
Sep 27, 2019
Last update
Sep 27, 2019

Study contacts

Troy G Seelhammer, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Lidocaine · Sodium Bicarbonate

Start the discussion